Antonio Russo

17PUBLICATIONS
79CO-AUTHORS
Gene and molecular therapyEpidemiological methodsDisease surveillanceTraditional Chinese medicine and treatmentsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

|Mar 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability.

Luigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis

|Feb 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano

|Dec 02, 2025
Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study).

Luigi Francesco Iannone, Marina Romozzi, Antonio Russo

|Aug 28, 2025
Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence.

Antonio Russo, Marcello Silvestro, Ian Finkelstein

|Jun 03, 2025
No additional benefit with detoxification strategies: A real world experience in 200 patients with chronic migraine and either simple or complex MOH treated with CGRP monoclonal antibodies.

Marcello Silvestro, Ilaria Orologio, Pasquale Sozio

Pageof 3

Frequent Collaborators

7 joint publications

Raffaele Ornello

7 joint publications

Luigi Francesco Iannone

6 joint publications

Innocenzo Rainero

6 joint publications

Marina Romozzi